Of note, in our study, a negative correlation was found between cytotoxic T cells CD8+ and malignant cells PD-L1, and previous reports showed that the metastatic urothelial cancer response to anti-PD-L1 treatment involved the movement of CD8+ T cells from the cancer portion to the collagen-rich intermediate tumor portion (52). The gene discussed is CD8A; the disease is cancer.